Baker Bros. Advisors »

Abivax SA F shares owned by Baker Bros. Advisors

Quarter-by-quarter ownership of Abivax SA F (ABVX) shares owned by Baker Bros. Advisors from 13F filings

Historical chart of Baker Bros. Advisors investment in Abivax SA F

Tip: Access up to 7 years of quarterly data

All positions including Abivax SA F held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abivax SA F by Baker Bros. Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $74M 876k 84.90

More positions owned by Baker Bros. Advisors

BeOne Medicines Sponsored Ads (ONC)
Incyte Corporation (INCY)
Madrigal Pharmaceuticals (MDGL)
Insmed Incorporated Com Par $.01 (INSM)
ACADIA Pharmaceuticals (ACAD)
Summit Therapeutics (SMMT)
Rhythm Pharmaceuticals (RYTM)
Revolution Medicines (RVMD)
Celcuity (CELC)
Kymera Therapeutics (KYMR)
Kodiak Sciences (KOD)
Alkermes SHS (ALKS)
Abcellera Biologics (ABCL)
Edgewise Therapeutics (EWTX)
Kiniksa Pharmaceuticals International Ord Shs Cl A (KNSA)

View all positions for Baker Bros. Advisors

Top funds holding Abivax SA F

TCG Crossover Management
UBS Group
Darwin Global Management
Point72 Asset Management
Cormorant Asset Management
Paradigm Biocapital Advisors
Caligan Partners
FMR
ADAR1 Capital Management
Octagon Capital Advisors
Millennium Management
Vestal Point Capital
Adage Capital Partners GP
Baker Bros. Advisors
Farallon Capital Management

View all funds holding Abivax SA F